Health systems have worked diligently to ensure that they are in compliance with the revised USP Chapter <797> requirements. This Frontline Conversations session will focus on questions related to USP Chapter <797> with expert faculty for any size facility. This session follows two live webinars that summarized key revisions to the revised USP Chapter <797>, assessing facility and personnel, best practices for training and monitoring personnel, safety features of technologies and standardization of IV compounding, and how facilities can perform a gap analysis of its facility, personnel, policies, and environmental monitoring.
No formal presentation was planned for this session. Attendees submitted questions for the faculty experts.
Begin ActivityFaculty
Patricia C. Kienle, RPh, MPA, BCSCP, FASHP, Activity Chair, Director, Accreditation and Medication Safety, Cardinal Health
Glen J. Gard, CPhT-Adv, CSPT, FNHIA, National Director, Sterile Compounding & Pharmacy Compliance, Option Care Health
Abby Roth, CMQ/OE, Microbiologist, Pure Microbiology
Michael Ganio, PharmD, MS, BCSCP, FASHP, Senior Director, Pharmacy Practice and Quality, ASHP
Target Audience
This activity was planned to meet the educational needs of pharmacists, pharmacy technicians, and medication safety officers practicing in hospitals and health systems.
How It Works
Faculty addressed as many pre-submitted questions as able during the session. During the session, questions were also submitted via the chat.
CE Accreditation
Content Release Date: July 1, 2024
Expiration Date: May 21, 2025
CE Credits: There is no CE credit with this activity
Activity Fee: Free
Provided by ASHP. Supported by an educational grant from Pfizer Inc.
